Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.36B |
| 2 |
AT&T
T
|
+$117M |
| 3 |
PayPal
PYPL
|
+$95.6M |
| 4 |
eBay
EBAY
|
+$95.2M |
| 5 |
Adobe
ADBE
|
+$94.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$198M |
| 2 |
Walmart Inc
WMT
|
+$179M |
| 3 |
NVIDIA
NVDA
|
+$173M |
| 4 |
Johnson & Johnson
JNJ
|
+$144M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.76% |
| 2 | Healthcare | 9.26% |
| 3 | Consumer Discretionary | 9.01% |
| 4 | Financials | 8.43% |
| 5 | Communication Services | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Aaon
AAON
$7.77B
| $385K | ﹤0.01% |
+3,268
| New | +$401K |
|
602
Guardant Health
GH
$22.6B
| $383K | ﹤0.01% |
12,544
-5,596
| -31% | -$157K |
|
603
CorVel
CRVL
$3.19B
| $382K | ﹤0.01% |
3,429
-21,024
| -86% | -$2.35M |
|
604
Rambus
RMBS
$11B
| $378K | ﹤0.01% |
7,145
-54,003
| -88% | -$2.75M |
|
605
ICU Medical
ICUI
$4.61B
| $375K | ﹤0.01% |
2,415
-1,049
| -30% | -$177K |
|
606
RLI Corp
RLI
$5.89B
| $373K | ﹤0.01% |
4,522
-4,738
| -51% | -$393K |
|
607
Amgen
AMGN
$222B
| $369K | ﹤0.01% |
1,415
-1,957
| -58% | -$581K |
|
608
Pilgrim's Pride
PPC
$6.54B
| $361K | ﹤0.01% |
7,949
-18,127
| -70% | -$883K |
|
609
Okta
OKTA
$25.8B
| $357K | ﹤0.01% |
+4,533
| New | +$351K |
|
610
American Tower
AMT
$80.4B
| $354K | ﹤0.01% |
+1,931
| New | +$400K |
|
611
Envista
NVST
$4.52B
| $354K | ﹤0.01% |
18,345
-8,210
| -31% | -$162K |
|
612
AvalonBay Communities
AVB
$26.8B
| $352K | ﹤0.01% |
1,600
+697
| +77% | +$157K |
|
613
Choice Hotels
CHH
$4.8B
| $341K | ﹤0.01% |
2,400
-5,837
| -71% | -$826K |
|
614
Lear
LEA
$8.18B
| $341K | ﹤0.01% |
3,597
-41,145
| -92% | -$4.1M |
|
|
SF
615
Stifel
SF
$12.6B
| $340K | ﹤0.01% |
4,806
-11,418
| -70% | -$815K |
|
|
THS
616
DELISTED
Treehouse Foods
THS
| $339K | ﹤0.01% |
9,663
-23,068
| -70% | -$841K |
|
617
Domino's
DPZ
$11.6B
| $335K | ﹤0.01% |
798
-3,127
| -80% | -$1.37M |
|
|
AMED
618
DELISTED
Amedisys
AMED
| $335K | ﹤0.01% |
3,686
-9,138
| -71% | -$839K |
|
619
NovoCure
NVCR
$1.91B
| $331K | ﹤0.01% |
11,119
-28,264
| -72% | -$598K |
|
620
National Fuel Gas
NFG
$7.65B
| $324K | ﹤0.01% |
+5,337
| New | +$327K |
|
621
ZTO Express
ZTO
$17.9B
| $317K | ﹤0.01% |
16,201
-149,074
| -90% | -$3.27M |
|
622
BCE
BCE
$21.2B
| $316K | ﹤0.01% |
13,655
+614
| +5% | +$17.6K |
|
623
NXP Semiconductors
NXPI
$60.4B
| $312K | ﹤0.01% |
1,501
-35,900
| -96% | -$8.17M |
|
624
Perdoceo Education
PRDO
$2.12B
| $309K | ﹤0.01% |
11,685
-29,351
| -72% | -$722K |
|
625
Palomar
PLMR
$3.45B
| $309K | ﹤0.01% |
2,923
-14,506
| -83% | -$1.47M |
|
Similar funds
Ray Dalio's Q4 2024 Portfolio in Review
As of Q4 2024, Ray Dalio held 855 positions worth $21.8B, up 24% from $17.7B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Ray Dalio deployed $4.28B of net new capital in Q4 2024, opening 82 new positions and adding to 262 existing holdings. Its largest new stake was ServiceNow: 281,970 shares worth $59.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Procter & Gamble, an estimated $198M trimmed.
- Ray Dalio's largest Q4 2024 buy was ServiceNow: 281,970 shares worth $59.8M.
- Ray Dalio added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $4.36B increase.
- Ray Dalio's biggest Q4 2024 reduction was Procter & Gamble, cutting an estimated $198M.
- Ray Dalio fully exited Micron Technology in Q4 2024, selling an estimated $102M.
- Ray Dalio's ten largest holdings make up 43% of its $21.8B portfolio in Q4 2024.
- Ray Dalio opened 82 new positions and closed 164 in Q4 2024.
- Ray Dalio's portfolio value rose 24% quarter-over-quarter to $21.8B.
Based on Bridgewater Associates's 13F filing for Q4 2024, filed 13 Feb 2025.